Zobrazeno 1 - 10
of 65
pro vyhledávání: '"F. Prestinari"'
Autor:
F. Prestinari, Sebastiano Recalcati, Fabrizio Fantini, Marco Franzetti, T. Barbagallo, Stefania Piconi
Publikováno v:
Dermatologic Therapy
Publikováno v:
International Journal of Dermatology
Autor:
E. Dainese, F. Prestinari, A. Vanzati, A. Cogliardi, Fabrizio Fantini, L.A. Frasin, M.C. Provero, Sebastiano Recalcati, T. Barbagallo
Publikováno v:
Journal of the European Academy of Dermatology and Venereology
Publikováno v:
Photodermatology, Photoimmunology & Photomedicine. 23:229-233
Background: In recent years, narrow-band ultraviolet B (NB-UVB, 311–313 nm) has been found to be beneficial for early-stages mycosis fungoides (MF). The aim of this study is to investigate the effect of NB-UVB in 20 patients with early-stage MF. Me
Autor:
Valentina Trevisan, Marco Zecca, Elena Roveda, Eleonora Bellani, T. Barbagallo, F. Prestinari, Valeria Brazzelli, C. Rona, Franco Locatelli, Giovanni Borroni
Publikováno v:
Pediatric Dermatology. 23:175-178
Imatinib mesylate is a drug that has been recently approved for the treatment for chronic myeloid leukemia. It acts as a potent and selective inhibitor of BCR-ABL tyrosine kinase. It also inhibits both c-kit and platelet-derived growth factor recepto
Autor:
Valeria Brazzelli, C. Rona, A. De Silvestri, T. Barbagallo, F. Prestinari, Valentina Trevisan, Giovanni Borroni
Publikováno v:
Europe PubMed Central
Scopus-Elsevier
Scopus-Elsevier
Photochemotherapy with psoralen plus ultraviolet A (PUVA) and phototherapy with UVB narrow band (UVB-NB) are used in the treatment of psoriasis. Numerous studies have shown that the additional administration of either topical or systemic antipsoriati
Autor:
F. Prestinari, Valeria Brazzelli, Camilla Vassallo, Giovanni Borroni, T. Barbagallo, Olga Ciocca
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 18:467-470
Eosinophilic pustular folliculitis (EPF) is an unusual disease, first described in adult East Asians in 1970 by Ofuji. It is characterized by follicular papules and pustules tending to coalesce and form plaques involving the trunk, face and extremiti
Publikováno v:
Dermatology. 204:252-254
Autor:
F. Prestinari, Francesco Locatelli, Ester Orlandi, T. Barbagallo, C. Rona, Marco Zecca, Valeria Brazzelli, Francesco Passamonti, S. Villani, Giovanni Borroni
Background Imatinib mesylate (IM), the first-line treatment of chronic myeloid leukaemia (CML), is a tyrosine kinase inhibitor that targets those proteins involved in BCR-ABL signal transduction in CML, c-kit (KIT) and platelet-derived growth-factor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d790e30edff8d1727dfb72601087f496
http://hdl.handle.net/11383/2023287
http://hdl.handle.net/11383/2023287
Autor:
T. Barbagallo, Valeria Brazzelli, Camilla Vassallo, F. Prestinari, Manuela Agozzino, Maddalena Cespa, F. Vailati, Giovanni Borroni
Publikováno v:
Photodermatology, photoimmunologyphotomedicine. 22(4)
The treatment of vitiligo is still a challenge. Among various therapeutic modalities, phototherapy with UVB narrowband (UVB-NB) is presently considered a treatment of choice for this skin disease. The exact skin cancer risk deriving from UVB-NB is a